KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Land & Improvements (2016 - 2017)

Historic Land & Improvements for Regeneron Pharmaceuticals (REGN) over the last 5 years, with Q4 2017 value amounting to $192.8 million.

  • Regeneron Pharmaceuticals' Land & Improvements rose 8551.09% to $192.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was $192.8 million, marking a year-over-year increase of 8551.09%. This contributed to the annual value of $192.8 million for FY2017, which is 8551.09% up from last year.
  • Regeneron Pharmaceuticals' Land & Improvements amounted to $192.8 million in Q4 2017, which was up 8551.09% from $103.9 million recorded in Q4 2016.
  • In the past 5 years, Regeneron Pharmaceuticals' Land & Improvements ranged from a high of $192.8 million in Q4 2017 and a low of $2.8 million during Q4 2013
  • Its 5-year average for Land & Improvements is $76.0 million, with a median of $77.8 million in 2015.
  • In the last 5 years, Regeneron Pharmaceuticals' Land & Improvements changed by 0.0% in 2014 and then soared by 271163.29% in 2015.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Land & Improvements stood at $2.8 million in 2013, then changed by 0.0% to $2.8 million in 2014, then surged by 2711.63% to $77.8 million in 2015, then soared by 33.51% to $103.9 million in 2016, then surged by 85.51% to $192.8 million in 2017.
  • Its Land & Improvements was $192.8 million in Q4 2017, compared to $103.9 million in Q4 2016 and $77.8 million in Q4 2015.